1 |
Liu J, Zhou Z, Ma L, Li C, Lin Y, Yu T, Wei JF, Zhu L, Yao G. Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma. Cancer Cell Int 2021;21:453. [PMID: 34446007 DOI: 10.1186/s12935-021-02163-9] [Reference Citation Analysis]
|
2 |
Liu D, Yang X, Wu X. Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma. Front Immunol 2021;12:663495. [PMID: 34025664 DOI: 10.3389/fimmu.2021.663495] [Reference Citation Analysis]
|
3 |
Yan M, Hu J, Ping Y, Xu L, Liao G, Jiang Z, Pang B, Sun S, Zhang Y, Xiao Y, Li X. Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma. Front Immunol 2021;12:758288. [PMID: 34804045 DOI: 10.3389/fimmu.2021.758288] [Reference Citation Analysis]
|
4 |
Yuan Y, Zhu Z, Lan Y, Duan S, Zhu Z, Zhang X, Li G, Qu H, Feng Y, Cai H, Song Z. Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients. Front Immunol 2021;12:659444. [PMID: 34040608 DOI: 10.3389/fimmu.2021.659444] [Reference Citation Analysis]
|